Navigation Links
New therapeutic options for diabetes-related tissue injury
Date:7/4/2008

Toronto, ON, Canada Diabetes mellitus is a metabolic disorder characterized by altered glucose tolerance and impaired lipid and carbohydrate metabolism, and is associated with a number of complications directly resulting from hyperglycemiainduced inflammation. Vascular changes in diabetes lead to increased risk of myocardial infarction and stroke due to atherosclerosis, retinopathy, end-stage renal disease, debilitating neuropathies, poor wound healing, enhanced risk of infection, and periodontal disease. Studies of diabetic complications suggest that activation of the inflammatory response is mediated in large part by phagocytic cells, macrophages, and polymorphonuclear leukocytes. Both cell types assume an aggressive proinflammatory phenotype resulting from hyperglycemia.

Today, during the 86th General Session of the International Association for Dental Research, investigators from Boston University report results from a study demonstrating that omega-6 and omega-3 fatty acids are precursors to a powerful new genus of anti-inflammatory and pro-resolution mediators, coined 'resolvins' and 'protectins'. These new local mediators counter-regulate pro-inflammatory signals and return tissues to homeostasis. These mediators reverse several of the proinflammatory functional responses of polymorphonuclear leukocytes and macrophages in vitro and prevent inflammation in a variety of animal models, and exhibit potential for new therapeutic options for resolving inflammation and tissue injury in diabetes.


'/>"/>

Contact: Linda Hemphill
lhemphill@iadr.org
International & American Association for Dental Research
Source:Eurekalert

Page: 1

Related medicine news :

1. Transition Therapeutics Announces Executive Management Appointments
2. Precision Therapeutics President and CEO Sean McDonald Named Ernst & Young Entrepreneur of the Year(R) 2008 Regional Award Winner
3. 2008 International Federation of Adipose Therapeutics and Science (IFATS) Conference Date Set
4. ExonHit Presents Therapeutic and Diagnostic Programs for Alzheimers at ICAD 2008
5. Medline Announces Advanced Line of Therapeutic Mattresses, Operating Room Table Pads and Stretcher Pads
6. Jerry Steffl Joins Prime Therapeutics as Vice President, Government Affairs
7. Fischman receives Pharmacology/Therapeutics/Toxicology Research Award
8. Lupin Enters Into Marketing Alliance with ASCEND Therapeutics for Suprax(R) 400 mg Tablets in the U.S.
9. Nuvelo Announces Publication of Preclinical Data From Wnt Therapeutics Program
10. Special supplement on self-monitoring of blood glucose in diabetes technology & therapeutics
11. Self-Monitoring of Blood Glucose Highly Effective in Diabetes Care, According to a Special Issue of Diabetes Technology and Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... a breakthrough topical cream that’s the first in a new class of photodynamic ... the overall appearance of skin, visibly reduce outward signs of aging, and minimize ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... A stressful ... at work can also decrease overall productivity and performance in the workplace. The goal ... , During the last few weeks of April, Clearview Resolution Services will be shutting ...
(Date:4/25/2017)... ... April 25, 2017 , ... Lake Park Dental is ... using Invisalign® in Lutz, FL. With the help of this highly-effective, yet ... with fewer potential complications, more discretion and less pain. , Drs. Sarah Jockin, ...
(Date:4/25/2017)... , ... April 25, 2017 , ... Back Pain ... and back pain with a reputable physician in their area, announces the launch of ... patient information for patients who are looking for reputable physicians to help them with ...
(Date:4/25/2017)... ... April 25, 2017 , ... Emergency Physician and Distinguished Professor ... Outlier Leadership Series, Outliers in Writing, set to publish in summer 2017. , ... at the University of Arizona College of Medicine. He also serves as Medical Director ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Eyevensys, a private biotechnology company developing its ... that enables the safe, local, sustained production of therapeutic ... of ophthalmic diseases, announces it has received approval from ... to advance its technology into clinical development. ... The EyeCET platform uses ...
(Date:4/19/2017)... 2017 The Mobile X-Ray product segment is the ... during the forecast period Mobile X-Ray segment is ... mobile X-Ray devices market, which is estimated to be valued ... a CAGR of 7% over the forecast period. Mobile X-Ray ... than US$ 100 Mn in 2017 over 2016. The segment,s ...
(Date:4/19/2017)... 2017 The Global Effective Microorganisms (EM) ... report has covered and analysed the potential of Global Effective ... size, shares and growth factors. The report identifies and analyses ... in the global market. ... Browse 152 Tables and Figures, 6 Major Company Profiles, spread ...
Breaking Medicine Technology: